摘要
对44例子宫内膜癌和10例子宫内膜重度不典型增生进行p53、C-erbB-2及ER免疫组化研究,内膜癌阳性率分别为47.7%.95.5%和88.6%,重度不典型增生分别为0%、10%和100%。其结果提示:C-erbB-2可作为子宫内膜癌和子宫内膜重度不典型增生鉴别诊断指标之一。p53.C-erbB-2和ER配合检测对宫内膜癌预后判断及治疗选择具有临床意义。
Abstract Forty - four cases of endometrial cancer and ten cases of serious endometrial atypical hyperpalsia were studied for expression of p53, C - erbB - 2 and ER with immunohistochemical method. The positive rates of p53, C -erbB - 2 and ER in endometrial cancer were 47.7%, 95.5% and 88.6% ,and in serious endometrial atypical hyperplasia wcrc 0%,10%and 100%. The results showod that the C - erbB - 2 is one of sueful indicators of the differential diagnosis between endometrial cancer and serioue endometrial atypical hyperpalsia.The combination of p53, C - erbB - 2 and ER will have important clinical value on the evaluation of prognosia and the treatment of endometrial cancer.
出处
《重庆医科大学学报》
CAS
CSCD
1998年第1期34-36,共3页
Journal of Chongqing Medical University